Other
Antisera and other blood fractions, residual category
HSN 3002 12 90 (antisera and other blood fractions, other) is subject to Central Drugs Standard Control Organisation (CDSCO) registration and import licensing under the Drugs and Cosmetics Act, 1940. A current drug registration certificate and a valid import licence for drugs are mandatory at the bill-of-entry stage, along with a batch release certificate and certificate of analysis.
- Registration certificate from CDSCO
- Import licence from CDSCO
- Batch release certificate from manufacturer
- 1Obtain a valid drug registration certificate (document code 101dc1) and an import licence for drugs (document code 9111dc) from the Central Drugs Standard Control Organisation before filing the bill of entry. Both documents must be uploaded in e-Sanchit prior to out-of-charge.Drugs and Cosmetics Act, 1940 · e-Sanchit document codes 101dc1 and 9111dc
- 2Upload the certificate of analysis for drugs (document code 0010dc), the batch release certificate (document code 0030dc), and the label of the consignment (document code 0110dc) in e-Sanchit at the bill of entry. The proper officer will verify all five mandatory documents before granting out-of-charge.e-Sanchit document codes 0010dc, 0030dc, 0110dc
The most common error on this tariff line is presenting the registration certificate and import licence while omitting one or more of the product-level documents — certificate of analysis (0010dc), batch release certificate (0030dc), or consignment label (0110dc). All five document codes are individually verified by the proper officer; a missing batch release certificate alone is sufficient to withhold out-of-charge, triggering detention and demurrage regardless of the validity of the CDSCO licence.